Li Hui, Li Xi-Feng, Zhang Xin, He Xu-Ying, Duan Chuan-Zhi, Liu Yan-Chao
a Department of Neurosurgery , Southern Medical University , Zhujiang Hospital, 253# Industry Road, Guangzhou , Guangdong , RP China.
Int J Neurosci. 2016;126(3):243-8. doi: 10.3109/00207454.2015.1010648. Epub 2015 May 22.
Endovascular treatment is an attractive approach for the treatment of unruptured vertebral dissecting aneurysms, and includes internal trapping and stent-assisted coil embolization. However, the optimal therapy remains debatable. We reviewed our experience with both endovascular treatment modalities and compared the safety, efficacy, and short-term outcomes for each approach.
We retrospectively reviewed 65 consecutive patients with unruptured vertebral dissecting aneurysms who underwent endovascular treatment between January 2003 and January 2014. 24 patients underwent endovascular internal trapping (group A) while 41 patients underwent stent-assisted coiling (group B). Thirteen patients underwent single stent with coiling while 28 patients underwent double or three stent-assisted coiling. Short-term outcomes were evaluated using the modified Rankin Scale.
A favorable clinical outcome was achieved in 58 of 65 patients. Procedure-related complications included ischemic symptoms (n = 6) and recurrence (n = 4). There was no statistical difference in modified Rankin Scale scoring between groups. Group A patients had more ischemia symptoms compared with group B patients (p = 0.043), Group B patients had higher recurrence rates compared with group A patients, but the difference had no statistical significance (p = 1.00). However, recurrence only occurred in patients who underwent stent-assisted coiling alone (p = 0.046).
Stent-assisted coiling for unruptured vertebral dissecting aneurysms may maintain artery patency. Multilayer disposition of stents with coils may decrease complications and facilitate aneurysm occlusion. Larger, prospective studies are necessary to determine the long-term outcomes of reconstructive therapy.
血管内治疗是治疗未破裂椎动脉夹层动脉瘤的一种有吸引力的方法,包括血管内套扎术和支架辅助弹簧圈栓塞术。然而,最佳治疗方法仍存在争议。我们回顾了我们在这两种血管内治疗方式方面的经验,并比较了每种方法的安全性、有效性和短期疗效。
我们回顾性分析了2003年1月至2014年1月期间连续65例接受血管内治疗的未破裂椎动脉夹层动脉瘤患者。24例患者接受了血管内套扎术(A组),41例患者接受了支架辅助弹簧圈栓塞术(B组)。13例患者接受单支架联合弹簧圈栓塞,28例患者接受双支架或三支架辅助弹簧圈栓塞。使用改良Rankin量表评估短期疗效。
65例患者中有58例取得了良好的临床疗效。与手术相关的并发症包括缺血症状(n = 6)和复发(n = 4)。两组间改良Rankin量表评分无统计学差异。A组患者的缺血症状比B组患者更多(p = 0.043),B组患者的复发率高于A组患者,但差异无统计学意义(p = 1.00)。然而,复发仅发生在单纯接受支架辅助弹簧圈栓塞的患者中(p = 0.046)。
未破裂椎动脉夹层动脉瘤的支架辅助弹簧圈栓塞术可能维持动脉通畅。多层支架联合弹簧圈置入可能减少并发症并促进动脉瘤闭塞。需要进行更大规模的前瞻性研究来确定重建治疗的长期疗效。